Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05446259

Degenerative Cervical Myelopathy Repository

To create a research repository of patients with known degenerative cervical myelopathy (DCM) and a control cohort of subjects who have non-myelopathic spinal disease. This repository will be used to assess functional and/or biological measures that may allow for improved prediction of symptomatic progression and response to treatment in patients with DCM. In addition, this repository will be used to develop a risk assessment scale to accurately predict functional outcomes following operative management of DCM.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of degenerative cervical myelopathy
  • Diagnosis of cervical degenerative disease without myelopathy

Exclusion criteria

  • None outside or diagnostic requirements and age limits.

Treatment and study plan

Standard clinical care procedures and outcome measurements.

Other

Standard of care surgical interventions, imaging impressions, laboratory results, and outcome measurements will be collected and analyzed.

Primary outcomes

  1. Data comparison between DCM and control groups

    Time frame: 2 years

    This study is to determine biomarkers associated with DCM and analyze objective clinical measures to determine more predictable and potentially effective treatments for patients diagnosed with cervical myelopathy.

Study contacts

Contact information is provided by the study sponsor or research team.

Francis Farhadi, MD, PhD

CONTACT

[email protected]

859-562-0247

Harshit Arora, PhD

CONTACT

[email protected]

859-323-4533

Sponsors and collaborators

Lead sponsor

Francis Farhadi

Other

Registry information

Official study title

Development of a Predictive Outcome Model for Patients With Degenerative Cervical Myelopathy Using Objective Functional and Biological Measures.

Acronym: DCM

Important dates

Study start
2022
Primary completion
2027
Study completion
2028
First posted
Jul 6, 2022
Registry last updated
Feb 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.